Dornase Alfa Inhalation Solution clinical trials
How each study uses Dornase Alfa Inhalation Solution is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 4
National Jewish Health (1) · University College, London (1) · University of Missouri-Columbia (1) · AO GENERIUM (1) · Fondation Ophtalmologique Adolphe de Rothschild (1)
Studies
Open first, then newest update. How each study uses Dornase Alfa Inhalation Solution is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Use of DNAse in Neutrophilic AsthmaCompletedPhase 1/2National Jewish HealthNCT03994380Written as RhDNAse Inhalation SolutionHow we know
- Nebulised Dornase Alfa for Treatment of COVID-19 (Coronavirus Disease 2019)CompletedPhase 2University College, LondonNCT04359654Written as Dornase Alfa Inhalation Solution [Pulmozyme]How we know
- Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE)TerminatedPhase 3Fondation Ophtalmologique Adolphe de RothschildNCT04355364Written as Dornase Alfa Inhalation Solution [Pulmozyme]How we know
- Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)CompletedPhase 3University of Missouri-ColumbiaNCT04402970Written as Dornase Alfa Inhalation SolutionHow we know
- Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic FibrosisCompletedPhase 3AO GENERIUMNCT04468100Written as Tigerase®How we know